BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33809119)

  • 1. Encapsulation and Enhanced Release of Resveratrol from Mesoporous Silica Nanoparticles for Melanoma Therapy.
    Marinheiro D; Ferreira BJML; Oskoei P; Oliveira H; Daniel-da-Silva AL
    Materials (Basel); 2021 Mar; 14(6):. PubMed ID: 33809119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy.
    Chaudhary Z; Subramaniam S; Khan GM; Abeer MM; Qu Z; Janjua T; Kumeria T; Batra J; Popat A
    Front Bioeng Biotechnol; 2019; 7():225. PubMed ID: 31620434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morin Hydrate Encapsulation and Release from Mesoporous Silica Nanoparticles for Melanoma Therapy.
    Cunha C; Marinheiro D; Ferreira BJML; Oliveira H; Daniel-da-Silva AL
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol-Loaded Polydimethylsiloxane-Silica Hybrid Materials: Synthesis, Characterization, and Antitumoral Activity.
    Viegas S; Marinheiro D; Bastos V; Daniel-da-Silva AL; Vieira R; Oliveira H; Almeida JC; Ferreira BJML
    Polymers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A composite hydrogel containing resveratrol-laden nanoparticles and platelet-derived extracellular vesicles promotes wound healing in diabetic mice.
    Zhu W; Dong Y; Xu P; Pan Q; Jia K; Jin P; Zhou M; Xu Y; Guo R; Cheng B
    Acta Biomater; 2022 Dec; 154():212-230. PubMed ID: 36309190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
    Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N; Saharkhiz S; Dini G; Yousefnia S
    Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer.
    Lin M; Yao W; Xiao Y; Dong Z; Huang W; Zhang F; Zhou X; Liang M
    Bioengineered; 2021 Dec; 12(1):6343-6353. PubMed ID: 34506231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
    Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
    Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method.
    Yang G; Li Z; Wu F; Chen M; Wang R; Zhu H; Li Q; Yuan Y
    Int J Nanomedicine; 2020; 15():1661-1675. PubMed ID: 32210559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Dissolution, Cellular Membrane Permeability, and Anti-Inflammatory Response of Resveratrol-Encapsulated Mesoporous Silica Nanoparticles.
    Juère E; Florek J; Bouchoucha M; Jambhrunkar S; Wong KY; Popat A; Kleitz F
    Mol Pharm; 2017 Dec; 14(12):4431-4441. PubMed ID: 29094948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol.
    Summerlin N; Qu Z; Pujara N; Sheng Y; Jambhrunkar S; McGuckin M; Popat A
    Colloids Surf B Biointerfaces; 2016 Aug; 144():1-7. PubMed ID: 27060664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of chlorophyll-loaded mesoporous silica nanoparticles for photodynamic therapy on cancer cell lines.
    Adnane F; Soliman SMA; ElZayat E; Abdelsalam EM; Fahmy HM
    Lasers Med Sci; 2024 Jan; 39(1):45. PubMed ID: 38253944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
    Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery and apoptosis induction activity of peptide-transferrin targeted mesoporous silica encapsulated resveratrol in MCF-7 cells.
    Li D; Song C; Zhang J; Zhao X
    J Pharm Pharmacol; 2023 Jan; 75(1):49-56. PubMed ID: 36173891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
    Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
    Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer.
    Fan C; Kong F; Shetti D; Zhang B; Yang Y; Wei K
    Biochem Biophys Res Commun; 2019 Nov; 519(2):378-384. PubMed ID: 31519327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
    Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
    Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia.
    Liu L; Yao W; Xie X; Gao J; Lu X
    J Nanobiotechnology; 2021 Aug; 19(1):235. PubMed ID: 34362394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.